Deutsche Bank
UTHR icon

Deutsche Bank’s United Therapeutics UTHR Stock Holding History

Deutsche Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-300
Closed -$10K – 5806
2013
Q4 		$10K Hold
300
– – ﹤0.01% 4894
2013
Q3 		$2K Buy
+300
New +$21.9K ﹤0.01% 5341

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Deutsche Bank's UTHR Position: Q1 2026 in Review

Deutsche Bank increased its United Therapeutics (UTHR) stake by 60% in Q1 2026, buying an estimated $37M and bringing the position to 198,777 shares worth $118M. The position accounts for 0.04% of the portfolio, ranked #423.

Deutsche Bank first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. The position peaked at $322M in Q2 2015. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Deutsche Bank held 198,777 shares of United Therapeutics worth $118M as of Q1 2026.
  • Deutsche Bank bought 74,302 United Therapeutics shares in Q1 2026, an estimated $37M.
  • United Therapeutics made up 0.04% of Deutsche Bank's portfolio in Q1 2026, its #423 holding.
  • Deutsche Bank first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's United Therapeutics position peaked at $322M in Q2 2015.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.